Evidence map›Paper›PMID 33784254›Full record

ArticleThe Journal of clinical investigation2021

Thymosin β4 protects against aortic aneurysm via endocytic regulation of growth factor signaling.

Sonali Munshaw, Susann Bruche, Andia N Redpath, Alisha Jones, Jyoti Patel, Karina N Dubé, Regent Lee, Svenja S Hester, Rachel Davies, Giles Neal and 5 more

Open access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Protective Role for Smooth Muscle Cell Hepcidin in Abdominal Aortic Aneurysm.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Sonali MunshawBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Susann BrucheBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Andia N RedpathBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Alisha JonesInstitute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Munich, Germany.
Jyoti PatelBHF Centre of Research Excellence, Division of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Karina N DubéUCL-Institute of Child Health, London, United Kingdom.
Regent LeeNuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Svenja S HesterNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford, United Kingdom.
Rachel DaviesBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Giles NealBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Ashok HandaNuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Michael SattlerInstitute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Munich, Germany.
Roman FischerNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford, United Kingdom.
Keith M ChannonBHF Centre of Research Excellence, Division of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Nicola SmartBurdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, University of Oxford, Sherrington Building, Oxford, United Kingdom.
Cardiff University · GBUniversity of Oxford · GBCenter for Integrated Protein Science Munich · DEJohn Radcliffe Hospital · GBInstitute of Child Health · IN

Funding

British Heart Foundation CH/16/1/32013British Heart Foundation FS/13/4/30045British Heart Foundation PG/15/35/31403Medical Research Council 18/19_MSD_1202143
6 · The paper itself

Abstract

Vascular stability and tone are maintained by contractile smooth muscle cells (VSMCs). However, injury-induced growth factors stimulate a contractile-synthetic phenotypic modulation which increases susceptibility to abdominal aortic aneurysm (AAA). As a regulator of embryonic VSMC differentiation, we hypothesized that Thymosin β4 (Tβ4) may function to maintain healthy vasculature throughout postnatal life. This was supported by the identification of an interaction with low density lipoprotein receptor related protein 1 (LRP1), an endocytic regulator of platelet-derived growth factor BB (PDGF-BB) signaling and VSMC proliferation. LRP1 variants have been implicated by genome-wide association studies with risk of AAA and other arterial diseases. Tβ4-null mice displayed aortic VSMC and elastin defects that phenocopy those of LRP1 mutants, and their compromised vascular integrity predisposed them to Angiotensin II-induced aneurysm formation. Aneurysmal vessels were characterized by enhanced VSMC phenotypic modulation and augmented PDGFR-β signaling. In vitro, enhanced sensitivity to PDGF-BB upon loss of Tβ4 was associated with dysregulated endocytosis, with increased recycling and reduced lysosomal targeting of LRP1-PDGFR-β. Accordingly, the exacerbated aneurysmal phenotype in Tβ4-null mice was rescued upon treatment with the PDGFR-β antagonist Imatinib. Our study identifies Tβ4 as a key regulator of LRP1 for maintaining vascular health, and provides insights into the mechanisms of growth factor-controlled VSMC phenotypic modulation underlying aortic disease progression.

Indexed as

Angiotensin IIAnimalsAortic Aneurysm, AbdominalBecaplerminLow Density Lipoprotein Receptor-Related Protein-1MaleMiceMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleReceptor, Platelet-Derived Growth Factor betaSignal TransductionThymosinThymosin beta(4)Angiotensin IIBecaplerminLow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseReceptor, Platelet-Derived Growth Factor betaThymosinThymosin beta(4)Cardiovascular diseaseSignal transductionVascular Biology

Identifiers

PMID33784254
PMCPMC8121525
OpenAlexW3151543642

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.